Home » Topics » BioWorld Science

BioWorld Science
RSS

Sorriso closes Series A financing to advance pipeline for immune-mediated diseases

Dec. 22, 2021

HPIs show promise for treating herpes simplex viral infection in a murine model

Dec. 22, 2021

CIRBP as promising biomarker to identify high-risk patients with IPF

Dec. 22, 2021

Alnylam submits CTA in U.K. for ALN-XDH to treat gout

Dec. 22, 2021

R-107 improves multiorgan functioning in a sheep model of sepsis

Dec. 22, 2021

IL-27-producing natural regulatory B-1a cells protect from CNS autoimmune diseases

Dec. 22, 2021

PSMA-targeted docetaxel conjugate with high antitumor activity and improved toxicity and solubility

Dec. 22, 2021

Discovery of novel chalcone derivatives for the treatment of neurodegenerative disorders

Dec. 22, 2021

Discovery of a familial intracranial aneurysm gene

Dec. 22, 2021

OAB-14 restores dysfunction of endosomal-autophagic-lysosomal pathway in APP/PS1 mice

Dec. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...